These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 16874361)

  • 1. Evaluation of adenovirus vectors containing serotype 35 fibers for tumor targeting.
    Ni S; Gaggar A; Di Paolo N; Li ZY; Liu Y; Strauss R; Sova P; Morihara J; Feng Q; Kiviat N; Touré P; Sow PS; Lieber A
    Cancer Gene Ther; 2006 Dec; 13(12):1072-81. PubMed ID: 16874361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adenovirus serotype 35 vector-induced innate immune responses in dendritic cells derived from wild-type and human CD46-transgenic mice: Comparison with a fiber-substituted Ad vector containing fiber proteins of Ad serotype 35.
    Sakurai F; Nakashima K; Yamaguchi T; Ichinose T; Kawabata K; Hayakawa T; Mizuguchi H
    J Control Release; 2010 Dec; 148(2):212-8. PubMed ID: 20800630
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus serotype 35 vector-mediated transduction into human CD46-transgenic mice.
    Sakurai F; Kawabata K; Koizumi N; Inoue N; Okabe M; Yamaguchi T; Hayakawa T; Mizuguchi H
    Gene Ther; 2006 Jul; 13(14):1118-26. PubMed ID: 16541121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Downregulation of human CD46 by adenovirus serotype 35 vectors.
    Sakurai F; Akitomo K; Kawabata K; Hayakawa T; Mizuguchi H
    Gene Ther; 2007 Jun; 14(11):912-9. PubMed ID: 17377598
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting of adenovirus vectors to tumor cells does not enable efficient transduction of breast cancer metastases.
    Shayakhmetov DM; Li ZY; Ni S; Lieber A
    Cancer Res; 2002 Feb; 62(4):1063-8. PubMed ID: 11861383
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of adenovirus vectors containing serotype 35 fibers for vaccination.
    DiPaolo N; Ni S; Gaggar A; Strauss R; Tuve S; Li ZY; Stone D; Shayakhmetov D; Kiviat N; Touré P; Sow S; Horvat B; Lieber A
    Mol Ther; 2006 Apr; 13(4):756-65. PubMed ID: 16461009
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of biodistribution and safety of adenovirus vectors containing group B fibers after intravenous injection into baboons.
    Ni S; Bernt K; Gaggar A; Li ZY; Kiem HP; Lieber A
    Hum Gene Ther; 2005 Jun; 16(6):664-77. PubMed ID: 15960598
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A human adenoviral vector with a chimeric fiber from canine adenovirus type 1 results in novel expanded tropism for cancer gene therapy.
    Stoff-Khalili MA; Rivera AA; Glasgow JN; Le LP; Stoff A; Everts M; Tsuruta Y; Kawakami Y; Bauerschmitz GJ; Mathis JM; Pereboeva L; Seigal GP; Dall P; Curiel DT
    Gene Ther; 2005 Dec; 12(23):1696-706. PubMed ID: 16034451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improved glioblastoma treatment with Ad5/35 fiber chimeric conditionally replicating adenoviruses.
    Hoffmann D; Meyer B; Wildner O
    J Gene Med; 2007 Sep; 9(9):764-78. PubMed ID: 17640083
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trans-complementing adenoviral vectors for oncolytic therapy of malignant melanoma.
    Wolkersdörfer GW; Morris JC; Ehninger G; Ramsey WJ
    J Gene Med; 2004 Jun; 6(6):652-62. PubMed ID: 15170736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fiber-chimeric adenoviruses expressing fibers from serotype 16 and 50 improve gene transfer to human pancreatic adenocarcinoma.
    Kuhlmann KF; van Geer MA; Bakker CT; Dekker JE; Havenga MJ; Elferink RP; Gouma DJ; Bosma PJ; Wesseling JG
    Cancer Gene Ther; 2009 Jul; 16(7):585-97. PubMed ID: 19180144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fiber-knob modifications enhance adenoviral tropism and gene transfer in malignant glioma.
    Zheng S; Ulasov IV; Han Y; Tyler MA; Zhu ZB; Lesniak MS
    J Gene Med; 2007 Mar; 9(3):151-60. PubMed ID: 17351980
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased infectivity of adenovirus type 5 bearing type 11 or type 35 fibers to human esophageal and oral carcinoma cells.
    Yu L; Takenobu H; Shimozato O; Kawamura K; Nimura Y; Seki N; Uzawa K; Tanzawa H; Shimada H; Ochiai T; Tagawa M
    Oncol Rep; 2005 Oct; 14(4):831-5. PubMed ID: 16142339
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD46 represents a target for adenoviral gene therapy of malignant glioma.
    Ulasov IV; Tyler MA; Zheng S; Han Y; Lesniak MS
    Hum Gene Ther; 2006 May; 17(5):556-64. PubMed ID: 16716112
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenovirus serotype 35 vector-mediated transduction following direct administration into organs of nonhuman primates.
    Sakurai F; Nakamura SI; Akitomo K; Shibata H; Terao K; Kawabata K; Hayakawa T; Mizuguchi H
    Gene Ther; 2009 Feb; 16(2):297-302. PubMed ID: 18800152
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Head and neck cancer cells are efficiently infected by Ad5/35 hybrid virus.
    Suominen E; Toivonen R; Grenman R; Savontaus M
    J Gene Med; 2006 Oct; 8(10):1223-31. PubMed ID: 16941521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oncolytic adenovirus based on serotype 3.
    Hemminki O; Bauerschmitz G; Hemmi S; Lavilla-Alonso S; Diaconu I; Guse K; Koski A; Desmond RA; Lappalainen M; Kanerva A; Cerullo V; Pesonen S; Hemminki A
    Cancer Gene Ther; 2011 Apr; 18(4):288-96. PubMed ID: 21183947
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficient gene transfer into hematopoietic cells by a retargeting adenoviral vector system with a chimeric fiber of adenovirus serotype 5 and 11p.
    Lu ZZ; Ni F; Hu ZB; Wang L; Wang H; Zhang QW; Huang WR; Wu CT; Wang LS
    Exp Hematol; 2006 Sep; 34(9):1171-82. PubMed ID: 16939810
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An adenoviral type 5 vector carrying a type 35 fiber as a vaccine vehicle: DC targeting, cross neutralization, and immunogenicity.
    Ophorst OJ; Kostense S; Goudsmit J; De Swart RL; Verhaagh S; Zakhartchouk A; Van Meijer M; Sprangers M; Van Amerongen G; Yüksel S; Osterhaus AD; Havenga MJ
    Vaccine; 2004 Aug; 22(23-24):3035-44. PubMed ID: 15297053
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of biodistribution of a fiber-chimeric, conditionally replication-competent (oncolytic) adenovirus in CD46 receptor transgenic mice.
    Ganesh S; Gonzalez-Edick M; Gibbons D; Waugh J; Van Roey M; Jooss K
    Hum Gene Ther; 2009 Oct; 20(10):1201-13. PubMed ID: 19572803
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.